Aristo Bio-Tech And Lifescience Limited — Others, 14-08-2025: Appointment

Aristo Bio-Tech and Lifescience's Board has approved the Annual Report for FY2024-25. The company will hold its 20th Annual General Meeting (AGM) on September 08, 2025, virtually. Shareholders can expect a final dividend of Re 0.50 per equity share for FY2024-25, with September 01, 2025, as the record date for eligibility. The Board also approved the re-appointment of Prakash Chandra Jain & Co. as Statutory Auditors for four more years, subject to shareholder approval at the AGM, and appointed Y.S. Thakar & Co. as Cost Auditors for FY2025-26.